1. Assessing treatment in early prostatic cancer is difficult.

2. This has never been shown for prostatic cancer.

3. Local eradication of prostatic cancer probably occurs more commonly with radical prostatectomy than with radiotherapy.

4. This study shows that prostatic disease explains only part of the increased male incidence.

5. Many undiagnosed patients with prostatic obstruction were referred to the renal unit.

6. Sacks etal highlighted the importance of prostatic disease as a preventable and treatable cause of renal failure.

7. The authors indicate therefore that excesses of prostatic cancer in industrial workforces are unlikely to be due to external radiation.

8. Prostatic disorder: Abnormality or disease of the prostate gland.

9. However, prostatic hyperplasia is not a premalignant lesion.

10. Prostatic fluid secreted by the male hormone regulation.

11. This proved to be prostatic adenocarcinoma.

12. Objective To study the therapeutical method of benign prostatic hyperplasia ( BPH ) complicated with vesical calculi.

13. Benign prostatic hyperplasia ( BPH ) and prostatitis are two common diseases in aging men.

14. Methods 486 cases of prostatic hyperplasia received intravesical suture of prostatic artery during suprapubic transvesical prostatectomy.

15. Conclusion CSEA for elderly patients with benign prostatic hyperplasia by transurethral resection of the prostate safe and effective, it is an ideal method of anesthesia.

16. Human prostatic acid phosphatase (ACPP) and prostate specific antigen (PSA) have been used as diagnostic and prognostic markers of prostate cancer.

17. Methods 42 cases with benign prostatic hypertrophy combining detrusor amyotonia were divided into two groups at random.

18. Likewise, prostatic enlargement known as BPH ( Benign Prostatic Hypertrophy ) also increases with advancing age.

19. Muscular tension is often a factor, and may be considered to be the prostatic version of a tension headache.

20. The authors do not state whether they actually treated the patients found to have prostatic cancer.

21. Tumours of this size are not identified clinically except incidentally in surgical specimens removed because of benign prostatic hyperplasia.

22. Opinion is divided about the value of screening for prostatic cancer and about the management of localised disease.

23. Obstruction covered all mechanical obstruction to the urinary tract, excluding prostatic disease.

24. AIM: To study the atrophy and apoptosis effect of flutamide (Flu) and 2 hydroxyflutamide (HF) on the benign prostatic hypertrophy (BPH) of rats.

25. To use A-G nomogram and AG number for diagnosing and quantitating the bladder outflow obstruction (BOO), 205 patients with benign prostatic hyperplasia (BPH) underwent the pressure-flow studies.

26. Methods: Retrospective analyses were made of the clinical data of 3 cases of ejaculatory duct obstruction following prostatic hyperthermia.

27. Using urethroscopy under a semi-tumescent penis, an isolated urethral injury with active bleeding was detected at the prostatic urethra.

28. Prophylactic urethrectomy is also performed in patients at high risk for recurrence, and is usually advocated for men with TCC of the prostatic stroma.

29. Objective To find out the changes of blood glucose in the surgery of transurethral prostatic vaporized electrocision.

30. Prominent nucleoli are seen in the nuclei of this prostatic adenocarcinoma, which is a characteristic feature.

31. Saw Palmetto, Pygeum, nettle and beta sitosterol are useful for benign prostatic hypertrophy ( BPH ).

32. Methods In 170 cases of benign prostatic hyperplasia (BHP), transurethral resection of the prostate was performed with trial improvements.

33. Objective To explore the regional distribution characteristic of morphosis and cellular proliferation in benign prostatic hyperplasia.

34. D : We found a lot of white cells and clumping of leukocytes of your prostatic secretion.

35. It is also shown that 77.81% at least can be decreased in blood supply of the prostate gland as the prostatic arterial trunk and the accessory pudendal artery are ligated.

36. Objective To review the diagnosis and treatment of the prostatic utricle associated with hypospadias.

37. Objective Comparison of suprapubic prostatectomy(SPP)and transurethral resection of the prostate (TURP) treatment of benign prostatic hyperplasia (BPH) efficacy.

38. Objective To explore the clinical application of endourological treatment of prostatic hyperplasia complicated with bladder stone.

39. Methods Since 1995 transplantation of pieces of dissociated bladder mucosa on to the prostatic cavity wall was carried out in 98 cases after prostatectomy to prevent hemorrhage and urethrostenosis.

40. Objective To evaluate the use of two - channel - single - balloon prostatic irrigation catheter in the treatment of chronic prostatitis.

41. Obstruction from nodular prostatic hyperplasia has led to prominent trabeculation seen on the mucosal surface of this bladder with hypertrophy.

42. A group of scientists examined some of this ejaculatory fluid and discovered prostatic enzymes, fuelling the theory that the G-spot is the equivalent of the male prostate.

43. Objective To compare the clinical efficacy of transrectal ultrasound guided prostatic nerve blockade with intrarectal 2% lidocaine gel for pain control during transrectal prostate biopsy.

44. Objective: To investigate the characteristics of diagnosis and treatment of iatrogenic ejaculatory duct obstruction following prostatic hyperthermia.

45. Objective To explore the clinical application of endourological treatment of benign prostatic hyperplasia complicated with bladder stone.

46. B sonography and MRI are excellent imaging modalities for accurately depicting prostatic utricle cyst.

47. Specializes in the treatment of prostatitis, prostatic hyperplasia, dysfunction, urinary tract infection and other diseases.

48. In particular, it may prevent hormone - dependent diseases, such as cancer,[] prostate cancer and benign prostatic hyperplasia.

49. Objective : To assess the value of transrectal ultrasonography ( TRUS ) in the diagnosis of midline prostatic cysts.

50. Objective:To observe the safety and efficacy of ropivacaine combined with tramadol in variable doses for lumber anesthesia in the transurethral prostatic electroresection of the aged.

51. That is because after age 50 many men face an embarrassing problem called B.P.H., for benign prostatic hyperplasia.

52. This case highlights the importance of early and accurate diagnosis of emphysematous prostatic abscess followed by appropriate treatment.

53. Objective : To investigate the mechanism of Chuan Shen Tong Injection ( CSTI ) for benign prostatic hyperplasia ( BPH ) .

54. Transurethral resection of the prostate (TURP) is the most common surgical procedure for relieving symptoms of benign prostatic hyperplasia.

55. Nerve or chemical stimulation can make the normal adult male prostatic fluid secretion increased significantly.

56. Objective To explore the pathologic diagnosis and differentiated diagnosis of the prostatic adenocarcinoma of needle biopsy.

57. He Specializes in prostatitis, benign prostatic hyperplasia diagnosis ( hypertrophy ) and male erectile dysfunction treatment.

58. Objective:To study the effect of prostatectomy on nocturia in men with benign prostatic hyperplasia (BPH).

59. Not only apoptosis also atrophy and necrosis could be observed in prostatic tissue after castration.

60. Objective To observe the therapeutic effect of super-selective embolism and chemotherapy in internal iliac artery on advanced prostatic carcinoma.

61. Conclusion To apply the prostate stents in prostatic hypertrophy was safety.

62. OBJECTIVE To explore action mechanism of total flavonoids from Bastard Speedwell (TFBS) on prostatic hyperplasia rats model induced by castration and testosterone propionate.

63. From 1985 to 1988, 74 patients of this Hospital developed contracture of the bladder neck (CBN) after transurethral resection of the prostate (TURP) to treat benign prostatic hyperplasia(BPH).

64. Methods: The prostatic fluids from 136 male patients with gonorrhoeae and NGU assayed with microscope.

65. Objective To investigate the clinical efficacy and safety of the transurethral resection of the prostate(TURP) on patients with high-risk benign prostatic hyperplasia(BPH).

66. Methods We observed and visited the effect of 34 cases who were treated on benign prostatic hyperplasia with vacuum aspiration in successively transurethral washing-resectoscope.

67. OBJECTIVE To observe the therapeutic effect of extracts from the root of Urtica dioica on prostatic hyperplasia in mice.

68. Objective : To evaluate the technique of TUR for Benign Prostatic Hyperplasia with small volume.

69. Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.

70. Benign Prostatic Hyperplasia is a common disease among the aging male, which characterised by dysuria or even anuresis.

71. Objective To study the inhibition of vibramycin on the expression of matrix metalloproteinase 2 (MMP 2) and the invasiveness of androgen independent prostatic carcinoma cell line PC 3 in vitro.

72. Results The prostatic blood supply originated mainly from inferior vesical artery or internal pudendal artery or prostatic artery (80%).

73. Decreased likelihood of developing certain hormone-dependent illnesses such as testicular cancer, prostate hypertrophy, prostatic cancer, mammary cancer and pyometra.

74. Objective To explore the influential factors leading to postoperative delirium in benign prostatic hyperplasia ( BPH ) patients.

75. This paper introduces a negative feedback instrument of HF electrosurgery. It dispels the deficiency in operation of benign prostatic hyperplasia and protected the patient from injury.

76. Objective To study the diagnosis and treatment of prostatic malakoplakia.

77. Objective To investigate the effect of prostate specific antigen (PSA) and levels of sex hormones as well as prostatic acid phosphatase (PAP) on prostatic size.

78. Objective To evaluate the clinical and pathological factors that may influence serum prostate specific antigen(PSA)level in patients with benign prostatic hyperplasia(BPH).

79. Here,[http:///prostatic.html] we report a rare case of emphysematous prostatic abscess due to candidiasis in a 68-year-old man with diabetes and liver cirrhosis.

80. Conclusions Bilateral orchiectomy for incidental prostatic carcinoma might improve the patients survival rate.

81. Objective To study the safe and effective method for endoscopic treatment of benign prostatic hyperpiesia(BPH) with bladder calculi.

82. Conclusion TVP combined with emasculation is a less invasive, effective operative way fort he treatment of patients with advanced prostatic cancer associated with bladder neck obstruction.

83. Objective: To supply means and data of the symptom sign study of the benign prostatic hyperplasia (BPH) through establishing a questionary of BPH.

84. DNA methylation has also been found in premalignant lesions such as prostatic intraepithelial neoplasia, but to a less extent compared with that in prostate cancer.

85. Renal cell carcinomas tend to be osteolytic (they destroy the bone) whereas prostatic adenocarcinomas tend to be osteoblastic (they initiate new bone formation).

86. OBJECTIVE: To determine the effect of terazosin on benign prostatic hyperplasia ( BPH ) and its safety.

87. Objective:To observe the effects of transurethral vaporization for prostate (TVP) and suprapubic prostatectomy (SPP) on sexual function of the patients with benign prostatic hyperplasia (BPH).

88. Herein we report a case of melioidosis presenting with a rare combination of septic arthritis, prostatic abscess, and septicemia.

89. Objective : To discuss the correlative parameters of PSA in evaluation of early prostatic cancer diagnosis.

90. We conclude that TUNA is effective for patients with urinary retention due to benign prostatic hyperplasia.

91. Objective:To investigate the clinical characteristics, diagnostic methods and minimally invasive treatment of prostatic utricle cyst.

92. To explore the diagnosis and treatment of prostatic utricle cyst.

93. At high magnification, this poorly differentiated prostatic adenocarcinoma demonstrates cells with nucleoli and mitotic figures.

94. Staging of prostatic adenocarcinoma is based upon how extensive the tumor is.

95. Conclusion TURP and general therapies can improve the life quality of patients with prostatic cancer.

96. METHODS Bacterial cultivation and drug - sensitivity test of prostatic fluid were used.

97. Objective To investigate the causes and treatment of bleeding after transurethral resection of the prostate(TURP) for benign prostatic hyperplasia(BPH).

98. Prostatic fluid contains a large number of zinc ions, has a strong bactericidal action.

99. Features new material on high resolution chest CT, prostatic and testicular ultrasound and expanded coverage of GI tract and obstetric ultrasound.

100. Objectve To study the neuro electrophysiologic mechanism underlying the inhibition of resiniferatoxin ( RTX ) to prostatic pain.

101. Methods: We retrospectively analyzed the TRUS manifestations of 87 cases of midline prostatic cysts.

102. Objective : To study on inhibiting effect of daidzein on Benign Prostatic Hyperplasia of mice.

103. Objective To explore the relationship between pain from prostatic inflammation and activation of astroglia in the spinal cord.

104. Furosemide should be used with care in patients with prostatic hypertrophy or impairment of micturition.

105. Conclusions The incidence and degree of enlarged prostatic utricle was increased according to the severity of hypospadias[sentencedict .com], and the occurrence of postoperative fistula was also increased as well.

106. AIM:To study the active chemical constituents of Pteris multifida against growth of rat prostatic epithelial cells(PECs).

107. Objective: To evaluate the diagnosis and prognosis value of serum prostate specific antigen(PSA) and prostate specific antigen density(PSAD) in patients with prostatic adenocarcinoma.

108. Modern medical research thinks, prostatic hyperplasia is middle - aged man body metabolic disorder.

109. Mycete were found in expressed prostatic secretions from 3 patients.

110. The international prostatic symptom score (I-PSS) and urodynamic studies (UFR) were carried out in 21 women with voiding disorders and in 102 women randomly selected from the population.

111. Objective:To probe the diagnosis with ureteroscopy for patients suffered with pudental hypospadias combining prostatic utricle.